GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Earnings Yield (Joel Greenblatt) %

Achiko AG (Achiko AG) Earnings Yield (Joel Greenblatt) % : 0.00% (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Earnings Yield (Joel Greenblatt) %?

Achiko AG's Enterprise Value for the quarter that ended in Jun. 2022 was $10.72 Mil. Achiko AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2022 was $-5.76 Mil. Achiko AG's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2022 was 0.00%.

The historical rank and industry rank for Achiko AG's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

ACHKF's Earnings Yield (Joel Greenblatt) % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.69
* Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Achiko AG's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2022 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Achiko AG Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for Achiko AG's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Earnings Yield (Joel Greenblatt) % Chart

Achiko AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21
Earnings Yield (Joel Greenblatt) %
- -8.51 -36.36 -31.25

Achiko AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial - -36.36 - -31.25 -

Competitive Comparison of Achiko AG's Earnings Yield (Joel Greenblatt) %

For the Health Information Services subindustry, Achiko AG's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Achiko AG's Earnings Yield (Joel Greenblatt) % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Achiko AG's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Achiko AG's Earnings Yield (Joel Greenblatt) % falls into.



Achiko AG Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Achiko AGs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2021 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-8.443/33.9526756
=-24.87 %

For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.



Achiko AG  (OTCPK:ACHKF) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Achiko AG Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Achiko AG's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Achiko AG (Achiko AG) Business Description

Traded in Other Exchanges
N/A
Address
Tessinerplatz 7, Zurich, CHE, CH-8002
Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.